234 related articles for article (PubMed ID: 17572386)
1. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.
Lamothe B; Webster WK; Gopinathan A; Besse A; Campos AD; Darnay BG
Biochem Biophys Res Commun; 2007 Aug; 359(4):1044-9. PubMed ID: 17572386
[TBL] [Abstract][Full Text] [Related]
2. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL.
Lamothe B; Campos AD; Webster WK; Gopinathan A; Hur L; Darnay BG
J Biol Chem; 2008 Sep; 283(36):24871-80. PubMed ID: 18617513
[TBL] [Abstract][Full Text] [Related]
3. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.
Lamothe B; Besse A; Campos AD; Webster WK; Wu H; Darnay BG
J Biol Chem; 2007 Feb; 282(6):4102-12. PubMed ID: 17135271
[TBL] [Abstract][Full Text] [Related]
4. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.
Zhang H; Wu C; Matesic LE; Li X; Wang Z; Boyce BF; Xing L
J Biol Chem; 2013 Aug; 288(31):22359-68. PubMed ID: 23782702
[TBL] [Abstract][Full Text] [Related]
6. Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling.
Strickson S; Emmerich CH; Goh ETH; Zhang J; Kelsall IR; Macartney T; Hastie CJ; Knebel A; Peggie M; Marchesi F; Arthur JSC; Cohen P
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3481-E3489. PubMed ID: 28404732
[TBL] [Abstract][Full Text] [Related]
7. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts.
Bai S; Zha J; Zhao H; Ross FP; Teitelbaum SL
J Biol Chem; 2008 Nov; 283(45):30861-7. PubMed ID: 18768464
[TBL] [Abstract][Full Text] [Related]
9. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
10. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
11. C-Cbl negatively regulates TRAF6-mediated NF-
Jang HD; Hwang HZ; Kim HS; Lee SY
Cell Mol Biol Lett; 2019; 24():29. PubMed ID: 31123462
[TBL] [Abstract][Full Text] [Related]
12. The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination.
Yang K; Zhu J; Sun S; Tang Y; Zhang B; Diao L; Wang C
Biochem Biophys Res Commun; 2004 Nov; 324(1):432-9. PubMed ID: 15465037
[TBL] [Abstract][Full Text] [Related]
13. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
[TBL] [Abstract][Full Text] [Related]
14. TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL.
Walsh MC; Kim GK; Maurizio PL; Molnar EE; Choi Y
PLoS One; 2008; 3(12):e4064. PubMed ID: 19112497
[TBL] [Abstract][Full Text] [Related]
15. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
Kobayashi N; Kadono Y; Naito A; Matsumoto K; Yamamoto T; Tanaka S; Inoue J
EMBO J; 2001 Mar; 20(6):1271-80. PubMed ID: 11250893
[TBL] [Abstract][Full Text] [Related]
16. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
Wang K; Li S; Gao Y; Feng X; Liu W; Luo R; Song Y; Ji Tu ; Liu Y; Yang C
Bone; 2018 Sep; 114():257-267. PubMed ID: 29933112
[TBL] [Abstract][Full Text] [Related]
17. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
[TBL] [Abstract][Full Text] [Related]
18. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides.
Poblenz AT; Jacoby JJ; Singh S; Darnay BG
Biochem Biophys Res Commun; 2007 Aug; 359(3):510-5. PubMed ID: 17544369
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.
Kim N; Kadono Y; Takami M; Lee J; Lee SH; Okada F; Kim JH; Kobayashi T; Odgren PR; Nakano H; Yeh WC; Lee SK; Lorenzo JA; Choi Y
J Exp Med; 2005 Sep; 202(5):589-95. PubMed ID: 16147974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
